Cours Windtree Therapeutics Inc Nasdaq
Actions
US97382D1054
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 1,99 M 1,82 M |
---|---|---|---|---|---|
Résultat net 2024 * | -21 M -19,19 M | Résultat net 2025 * | -29 M -26,51 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-0,22
x | PER 2025 * |
-0,33
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 95,99% |
Dernier transcript sur Windtree Therapeutics Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/02/16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/03/20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/02/21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/06/23 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/02/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+67,53% | 63,85 Md | |
-0,77% | 41,83 Md | |
+45,66% | 40,65 Md | |
-10,72% | 27,12 Md | |
+13,30% | 26,52 Md | |
-22,79% | 18,69 Md | |
+4,70% | 12,73 Md | |
+24,10% | 12,11 Md | |
+27,41% | 12,07 Md |